Latest Commercialization News

Tryptamine Therapeutics has enrolled the first patient in its pioneering clinical trial testing TRP-8803, an IV-infused psilocin formulation, for Binge Eating Disorder. The study aims to evaluate safety and efficacy, potentially reshaping treatment options for millions.

EMVision Medical Devices has received a $3 million government grant to fund a clinical study demonstrating its emu™ brain scanner's impact on accelerating stroke diagnosis in rural emergency departments.

Elixir Energy has confirmed 23 meters of net gas pay across three Permian formations at its Diona-1 well in Queensland, setting the stage for flow testing and potential near-term gas production.

ReNerve Limited has achieved its first commercial sales of the EmpliQ™ amniotic tissue products, marking a significant step in its transition from R&D to commercialisation. The EmpliQ™ range complements its existing nerve repair solutions and targets a growing global wound care market.

Catalyst Metals has received regulatory approval to build an exploration tunnel at its Four Eagles gold project in Victoria, marking a pivotal step toward underground access and resource expansion. The company is advancing its high-grade gold resource with a secured processing facility and plans for further drilling in FY26.

Odyssey Gold Limited has reported encouraging results from a technical study supporting open pit mining at its Tuckanarra Gold Project and signed a key Memorandum of Understanding to process ore at Monument Mining’s nearby Burnakura plant.

Patronus Resources reports a robust $70 million in cash and investments alongside 2.3 million ounces of gold equivalent resources, underpinning a multi-commodity growth strategy across Western Australia and the Northern Territory.

Pacific Edge reports a 9% decline in Cxbladder test volumes amid Medicare coverage loss but gains momentum with new clinical validation and a CMS pricing boost.

Latrobe Magnesium Limited (ASX – LMG) has launched an $8 million equity raising to fund the ramp-up of its magnesium metal production and advance feasibility studies for a larger commercial plant. The company’s patented hydromet process converts brown coal ash into sustainable magnesium with significantly lower emissions than global peers.

Latrobe Magnesium has locked in $10 million through a placement and entitlement offer to complete its demonstration plant and push towards commercial-scale magnesium production.

Cryosite Limited reports a strong start to FY26 with a 22% revenue increase and a strategic warehouse acquisition that doubles capacity, positioning the company for sustained growth in clinical trial logistics.

INOVIQ Limited has launched an A$11.5 million capital raise to fast-track clinical validation and commercialization of its ovarian cancer screening test and advance its CAR-exosome therapeutic program targeting solid tumors.